Mencuro Therapeutics Inc - KS Douglas, Lawrence 66049

Mencuro Therapeutics Inc entered the industry of Business Services (Unclassified) in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 561499, which describes it as a Business Services (Unclassified). For further clarification, the SIC classifies this business under the code 7389 and described it as a Business Services (Unclassified). The business provides service to the B2B market.

To acquire more information, please contact Robert Karr by calling (860) 938-2315 during business hours. You can also write to the business’ Single Location at 917 Diamondhead Drive, Lawrence, Kansas KS 66049. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Mencuro Therapeutics Inc
Representative: Robert Karr
Place of Business: 917 Diamondhead Drive, Lawrence, KS 66049
Contact Number: (860) 938-2315
Type of Service: Business Services (Unclassified)
SIC Number: 7389
NAICS Number: 561499
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2010
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Mencuro Therapeutics Inc is a company operating from Douglas, Kansas providing professional Business Services (Unclassified) and relevant B2B variables. It was founded in 2010 and registered with the SIC code 7389 as Business Services (Unclassified), and with the NAICS code 561499 as Business Services (Unclassified).

With a current employee count of 1 to 4, Mencuro Therapeutics Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Robert Karr at (860) 938-2315 for related queries, or to locate its Single Location using the coordinates 38.965122,-95.327616.

The Single Location can also be found at the street address 917 Diamondhead Drive in Lawrence, Kansas 66049 and can be engaged online through the company website at , the company Twitter , and Facebook page .